glp-1 agonist therapy consultation preparation Updated guidance for patients using GLP-1/GIP receptor agonists GLP-1 Patient Counseling: Balancing Evidence
Description
Think of Zepbound as using two complementary approaches simultaneously rather than relying on one very effective approach

Gastric bypass was associated with improvement of migraine in 89% of individuals

doi: 10.1159/000521264 Summary Keywords GLP-1R agonists, obesity, weight-reducing drugs, metabolic diseases, dual agonism Citation Wang J-Y, Wang Q-W, Yang X-Y, Yang W, Li D-R, Jin J-Y, Zhang H-C and Zhang X-F (2023) GLP1 receptor agonists for the treatment of obesity: Role as a promising approach

The incidence of acute pancreatitis, as confirmed by post-marketing monitoring data, are less than 0.1%, which is in line with the rates seen in the general diabetic population
